I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Piroxicam is an effective and potent inhibitor of prostaglandin synthesis and a Cox-1 and Cox-2 inhibitor. Studies show that Piroxicam blocks release of platelet ADP, and inhibits Cox-1 more potently than Cox-2.
V. Tantishaiyakul.; N. Kaewnopparat.; S. Ingkatawornwong. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. International Journal of Pharmaceutics. 1996, 143,(1), 59-66.
V. Tantishaiyakul.; N. Kaewnopparat.; S. Ingkatawornwong. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. International Journal of Pharmaceutics. 1999, 181,(2), 143-151.
Hazard Statements: H301
Toxic if swallowed.
Precautionary Statements: P264-P270-P301+P310a-P321-P405-P501a
Wash thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Specific treatment (see label). Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.